---
title: "Vertex Hits Record High After Goldman Adds Stock to Conviction List"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297799502.md"
description: "Vertex hit a record high after Goldman Sachs added it to the Conviction List, analysts maintain buy ratings."
datetime: "2026-09-02T14:13:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297799502.md)
  - [en](https://longbridge.com/en/news/297799502.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297799502.md)
generator: "portal-rs"
---

# Vertex Hits Record High After Goldman Adds Stock to Conviction List

福泰制药 (VRTX.US) 盘中涨超 1%，现报 555.57 美元，股价触及历史新高。

消息面上，高盛于 09/02/2026 更新秋季「Conviction List」，将福泰制药新纳入美股推荐名单，对其长期增长基本面持乐观态度。此外，公司近日任命 Jonathan Poole 为首席财务官，将于 2027 年 1 月 1 日生效；此前于 09/01/2026 完成对 Crinetics Pharmaceuticals 的收购，进一步拓展内分泌疾病治疗管线。多家机构近期增持该股，分析师普遍维持「买入」评级，平均目标价约 563 美元。

### Related Stocks

- [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md)

## Related News & Research

- [Vertex Pharmaceuticals Eyes Renal Growth With Key PDUFA, Pipeline Catalysts Ahead](https://longbridge.com/en/news/298914581.md)
- [Vertex (VRTX) Stock Still Looks Like A Bargain On Its 181% Run](https://longbridge.com/en/news/298484320.md)
- [VRTX: Diversified pipeline advances with global CF launches, renal expansion, and pivotal readouts ahead](https://longbridge.com/en/news/298920359.md)
- [Olympic skier Vonn joins up with Vertex for pain campaign](https://longbridge.com/en/news/299058605.md)
- [Vertex Pharmaceuticals Highlights Catalyst-Rich Pipeline Beyond Cystic Fibrosis](https://longbridge.com/en/news/298806080.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**